QSI enters agreement to acquire ViaTrack

Quality Systems, Inc. ("QSI") (NASDAQ: QSII), a leading provider of healthcare information systems and connectivity solutions, today announced that it has entered into an agreement to acquire ViaTrack Systems, a developer and provider of information technologies that enhance electronic data interchange (EDI) offerings.

ViaTrack has been a long-time EDI preferred partner of QSI's wholly owned subsidiary, NextGen Healthcare, during which time it delivered proactive, reliable and personalized electronic claim services to clients nationwide. ViaTrack will become part of QSI, continuing to support NextGen Healthcare's ambulatory clients, while also allowing NextGen Healthcare to leverage ViaTrack's infrastructure and technical expertise to offer full EDI services to its inpatient clients.

The acquisition of ViaTrack Systems allows NextGen Healthcare to accomplish its goal of expanding support for the inpatient EDI market and strengthen its ability to quickly respond to changes in the industry.

"The acquisition of ViaTrack will further expand our portfolio of inpatient solutions and demonstrates our commitment to supporting the hospital market through 5010, ICD-10, HIPAA and other key industry initiatives," noted Donn Neufeld, executive vice president, EDI and dental at Quality Systems. "We look forward to continuing to strengthen the relationships we have forged with our ambulatory clearinghouse partners, which, combined with this acquisition, afford us the ability to deliver a complete approach to EDI services across the continuum of care."

Allen Baker, ViaTrack president, added: "We are very excited about joining the QSI family and look forward to the development of many new features for our inpatient solutions clients. As in the past, we will continue to provide superior clearing house services for our existing clients with many new state-of-the-art features planned."

Source: Quality Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nutraceuticals: exploring potential benefits and challenges of an unregulated healthcare frontier